8 analysts have shared their evaluations of DexCom (NASDAQ:DXCM) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table encapsulates their recent ...
Ultra-Low Power ASIC Enables Commercialization of Novel Implantable Continuous Glucose Sensor POCATELLO, Idaho--Nov. 7, 2005--AMI Semiconductor (Nasdaq:AMIS), a designer and manufacturer of ...
DexCom, Inc. reduced its 2024 revenue guidance following a decline in new U.S. customers and revenue per customer, leading to a sharp share price drop, despite $750 million share buyback. DexCom faces ...
DexCom (NASDAQ:DXCM) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...
2023 was a banner year for Dexcom. Not only did it undertake a new major product launch, but it received the largest expansion of insurance coverage in the company’s history. And it’s got the receipts ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A warning letter posted Tuesday by the Food and Drug ...
Raymond James upgraded its rating of DexCom (NASDAQ:DXCM) to Strong Buy with a price target of $138.00, changing its price target from $127.00 to $138.00. Shares of DexCom are trading up 2.45% over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback